Trials show immune drugs effective in advanced melanomas
June 1, 2015 · Comments Off on Trials show immune drugs effective in advanced melanomas
Results of two clinical trials reported at the American Society for Clinical Oncology (ASCO) Annual Meeting 2015 show continued promise of immune therapies nivolumab and pembrolizumab against advanced melanomas, specifically in the context of PD1 signaling that some tumors use to avoid immune system attack.
May is melanoma awareness month: two stories, one goal
May 1, 2015 · Comments Off on May is melanoma awareness month: two stories, one goal
Colorado is known for mountains, sunshine and people who like to get outdoors all year...
8 reasons the U.S. Surgeon General should announce that UV tanning causes skin cancer
April 8, 2015 · Comments Off on 8 reasons the U.S. Surgeon General should announce that UV tanning causes skin cancer
"Tanning beds cause skin cancer. It is time to now more openly announce this causality," says Robert P. Dellavalle, MD, PhD, MSPH, investigator at the CU Cancer Center.
Beyond the Cover
December 15, 2014 · Comments Off on Beyond the Cover
Melanoma patient Kelly Howard endures an often invisible illness, while benefiting from breakthrough immunotherapy treatments....
Study Shows Link Between Genes, Seaside Vacations & Future Melanoma Risk
November 19, 2014 · Comments Off on Study Shows Link Between Genes, Seaside Vacations & Future Melanoma Risk
“Early-life UV exposure that confers risk for melanoma also plays a role in development of moles or melanocytic nevi, which can be both a biomarker for melanoma risk and occasionally an immediate precursor,” says Neil Box, PhD.
Next-Gen Melanoma Drug, TAK-733, Excels in Lab Tests
November 11, 2014 · Comments Off on Next-Gen Melanoma Drug, TAK-733, Excels in Lab Tests
A University of Colorado Cancer Center study published online this week in the journal Molecular Cancer Therapeutics reports anti-cancer activity in 10 out of 11 patient tumor samples grown in mice and treated with the experimental drug TAK-733, a small molecule inhibitor of MEK1/2.
Ebola Highlights Disparity of Disease Burden in Developed vs. Developing Countries
October 15, 2014 · Comments Off on Ebola Highlights Disparity of Disease Burden in Developed vs. Developing Countries
Study of skin conditions shows mortality rates for measles, syphilis, Ebola hundreds of times higher in developing countries than in developed countries. Study writes that findings, "Highlight the importance of monitoring disease burden in the developing world even when the burden is low."
Study of Dermatology on YouTube Shows New Ways Science Reaches Public
July 9, 2014 · Comments Off on Study of Dermatology on YouTube Shows New Ways Science Reaches Public
A CU Cancer Center study published in the Dermatology Online Journal shows that YouTube also allows researchers, journals, and health advocates to connect directly with the public on topics of skin cancer and prevention.
May is Skin Cancer Awareness Month: A Conversation with Dr. Neil Box
May 19, 2014 · Comments Off on May is Skin Cancer Awareness Month: A Conversation with Dr. Neil Box
Neil Box, PhD, is an assistant professor in the Department of Dermatology. In this interview...
November 18, 2015 · No comments
Study by Cathy J. Bradley, PhD, shows that for breast cancer survivors without prescription coverage, even relatively low-cost medicines can be “catastrophic”.
Study combats “anxiety” as barrier to breast cancer screening
October 22, 2015 · Comments Off on Study combats “anxiety” as barrier to breast cancer screening
CU Remote Second Opinion Program lets LA family "consult expert on Monday and still be in the Superdome for kickoff" coloradocancerblogs.org/expert-living-…
How I did on Twitter this week: 9 New Followers, 3 Mentions, 14.4K Mention Reach. How'd your week go? via sumall.com/myweek